Unlock AI-driven, actionable R&D insights for your next breakthrough.

Creatine Phosphate Reaction Yield: Comprehensive Analysis Of Synthesis Routes, Optimization Strategies, And Enzymatic Production Efficiency

NOV 17, 202666 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Creatine phosphate reaction yield represents a critical parameter in both industrial synthesis and biochemical applications, directly impacting production economics and diagnostic assay performance. This article examines quantitative yield data from multiple synthesis pathways, enzymatic production methods, and analytical determination techniques, providing research-grade insights into optimizing creatine phosphate formation efficiency across pharmaceutical manufacturing, clinical diagnostics, and bioenergetics research contexts.
Want to know more material grades? Try Patsnap Eureka Material.

Chemical Synthesis Routes And Yield Optimization For Creatine Phosphate Production

The chemical synthesis of creatine phosphate has been extensively investigated through multiple reaction pathways, with documented yields ranging from 73% to nearly quantitative conversion depending on substrate selection and reaction conditions. The most economically viable industrial route involves the enzymatic conversion of creatine with 3-phosphoglyceric acid in the presence of adenosine triphosphate (ATP) as a catalyst 4. This process achieves 80-90% theoretical yield within one hour at temperatures between 32°C and 40°C, with extended reaction times of 3-4 hours enabling 100% conversion 4. The reaction is conducted in an alkaline medium at pH 7.0-11.0, preferably pH 8.0-9.0, using aqueous muscle extract as the enzyme source 4.

A critical factor influencing yield is the molar ratio of reactants. Using an excess of creatine relative to 3-phosphoglyceric acid proves advantageous due to cost considerations, while ATP is added in catalytic quantities at approximately 1 equivalent per 60-100 equivalents of substrate 4. Reducing ATP concentration below this ratio extends reaction time without proportional economic benefit, whereas increasing it offers minimal technical advantage 4. The reaction is terminated by rapid heating to 70-100°C, preferably 80-90°C, which coagulates protein impurities and facilitates their removal by filtration 4. Recovery involves ion separation, solution concentration, and precipitation with alcohol at pH 8.0-8.5, typically with crystal seeding to enhance product formation 4.

Alternative synthesis approaches have been explored for related compounds. For creatinol O-phosphate, a protected intermediate strategy using sulfuric acid to form creatinol sulfate as a transition state significantly reduces N-substituted impurities and enhances reaction selectivity 6. This protection method, followed by reaction with POCl₃, ClPO₃H₂, or P₂O₅, increases both target product yield and purity 6. The creatinol compound is first dissolved in organic solvents such as butanone, ethyl acetate, or acetone, then sulfuric acid is slowly added to form the protected functional group before phosphorylation 6.

For creatine itself (a precursor to creatine phosphate), synthesis from urea and sodium sarcosinate under vacuum conditions has achieved 73.66% yield (222.5 kg product) 1. This method involves mixing aqueous solutions of the reactants, heating, and conducting insulation reactions, followed by cooling to 20°C, filtration, and drying 1. The process is characterized as non-toxic, environmentally friendly, and cost-effective due to inexpensive raw materials and simple operations 1.

Enzymatic Production Methods And Catalytic Efficiency In Creatine Phosphate Formation

Enzymatic production of creatine phosphate offers advantages in terms of reaction specificity and mild operating conditions. The primary enzymatic route utilizes creatine kinase (CK) to catalyze the reversible phosphorylation of creatine with ATP, forming creatine phosphate and adenosine diphosphate (ADP) 2357. This reaction is fundamental to cellular energy metabolism and has been extensively characterized for both synthetic and analytical applications.

The enzymatic synthesis process typically employs muscle extract as the enzyme source, which contains endogenous creatine kinase along with supporting metabolic enzymes 4. The reaction requires:

  • Substrate concentrations: Creatine at 10-100 mM and ATP at catalytic levels (1-2 mM) 4
  • pH optimization: Alkaline conditions (pH 7.0-11.0, optimally 8.0-9.0) 4
  • Temperature control: 32-40°C for optimal enzyme activity 4
  • Reaction time: 1-4 hours depending on desired conversion 4

The catalytic efficiency of creatine kinase is influenced by the presence of sulfhydryl-containing activators. N-acetylcysteine has been identified as a particularly stable activator for CK-catalyzed reactions, enabling the preparation of diagnostic reagents with extended shelf life 3. Other suitable sulfhydryl compounds include dithiothreitol, dithioerythritol, and reduced glutathione, though N-acetylcysteine is preferred for its superior stability 2. These activators maintain enzyme activity by protecting critical cysteine residues from oxidation.

The reverse reaction—ATP formation from creatine phosphate and ADP—is exploited in coupled enzymatic assays for CK activity determination. In these systems, the ATP produced is quantified through secondary reactions involving phosphoglycerate kinase (PGK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which consume NADH in a measurable optical signal 7. The Michaelis constant (K_M) for creatine in the CK-catalyzed reaction has been determined as 5 × 10⁻² M at 25°C and pH 7.6 9, providing kinetic parameters essential for optimizing reaction conditions.

Analytical Determination Of Creatine Kinase Activity And Reaction Yield Quantification

Accurate determination of creatine kinase activity is essential for both quality control in creatine phosphate production and clinical diagnostics. Multiple analytical methods have been developed, each with specific advantages for yield quantification and reaction monitoring.

Bioluminescence-Based Assay Systems

The most sensitive method for CK determination employs the firefly luciferase-luciferin system to detect ATP produced from creatine phosphate and ADP 25810. This approach achieves exceptional sensitivity by coupling the CK reaction with the light-emitting oxidation of luciferin:

  1. Creatine phosphate + ADP → Creatine + ATP (CK-catalyzed) 25
  2. ATP + Luciferin + O₂ → Oxyluciferin + AMP + Light (Luciferase-catalyzed) 25

Optimal assay conditions require:

  • ADP concentration: 0.1-10 mM at saturation levels 25
  • pH range: 5.8-7.5, preferably 6.3-7.2, optimally 6.5-6.9 25
  • Luciferase activity: ≥50 units per test 25
  • AMP concentration: 1-10 mM to inhibit adenylate kinase interference 25
  • Diadenosine pentaphosphate (Ap₅A): 1-100 μM, preferably 5-50 μM, to suppress adenylate kinase 25

The addition of AMP is critical for reducing background ATP concentration in samples, particularly in dried blood specimens where endogenous ATP can interfere with CK measurement 810. AMP at 125 mM effectively decomposes ATP before the addition of ADP and creatine phosphate, enabling accurate CK quantification 810. The correlation between this bioluminescence method and traditional spectrophotometric assays demonstrates excellent linearity across clinically relevant CK activity ranges 810.

Spectrophotometric Coupled-Enzyme Assays

An alternative approach utilizes a three-enzyme cascade to link CK activity to NADH oxidation, which is monitored at 334 nm, 340 nm, or 366 nm 7. The reaction sequence involves:

  1. Creatine phosphate + ADP → Creatine + ATP (CK) 7
  2. ATP + 3-Phosphoglycerate → ADP + 1,3-Diphosphoglycerate (PGK) 7
  3. 1,3-Diphosphoglycerate + NADH → Glyceraldehyde-3-phosphate + NAD⁺ + Pi (GAPDH) 7

This method employs phosphoglycerate kinase (PGK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as coupling enzymes in a buffer system (pH 6-9) containing tris(hydroxymethyl)aminomethane, imidazole, or triethanolamine 7. The rate of absorbance decrease at 340 nm (ΔA₃₄₀/min) is directly proportional to CK concentration, enabling quantitative determination of enzyme activity and, by extension, reaction yield in synthetic processes 7.

Interference Mitigation And Assay Optimization

A major challenge in CK assays is interference from adenylate kinase, which catalyzes the reaction 2 ADP ↔ ATP + AMP, generating ATP independent of CK activity 25810. This interference is effectively suppressed by:

  • Diadenosine pentaphosphate (Ap₅A): 0.2-2 μM completely inhibits adenylate kinase without affecting CK or luciferase 25810
  • Sodium fluoride: Alternative adenylate kinase inhibitor 25
  • Sequestering agents: EDTA, Trilone, Komplexone, or Sequestrene to chelate interfering metal ions 25
  • Stabilizers: Serum albumin to maintain enzyme stability during storage 25

The optimized assay conditions enable detection of CK activity with high specificity and sensitivity, making them suitable for monitoring reaction progress in creatine phosphate synthesis and for clinical diagnostics where CK activity changes indicate myocardial infarction severity 3.

Reaction Kinetics And Thermodynamic Considerations In Creatine Phosphate Synthesis

Understanding the kinetics and thermodynamics of creatine phosphate formation is essential for maximizing reaction yield and designing efficient production processes. The equilibrium position of the CK-catalyzed reaction is influenced by substrate concentrations, pH, temperature, and ionic strength.

The forward reaction (creatine phosphate formation) is thermodynamically favorable under conditions of high ATP and creatine concentrations, while the reverse reaction (ATP regeneration) is exploited in energy metabolism and analytical applications 247. The reaction exhibits pseudo-first-order kinetics when one substrate is maintained at saturating concentration, simplifying kinetic analysis and process optimization 2.

Temperature effects on reaction yield are complex. While elevated temperatures (32-40°C) enhance reaction rates by increasing molecular collision frequency and enzyme turnover, excessive heating (>45°C) risks enzyme denaturation and reduced catalytic efficiency 4. The optimal temperature range balances these competing factors, achieving 80-90% yield in one hour at 32-40°C 4. Extended incubation at these temperatures (3-4 hours) drives the reaction toward completion, achieving near-quantitative conversion 4.

pH optimization is critical for both enzyme stability and catalytic efficiency. The CK enzyme exhibits maximal activity at pH 8.0-9.0, where ionization states of active site residues favor substrate binding and catalysis 4. At pH values below 7.0 or above 11.0, enzyme activity declines due to protonation or deprotonation of critical amino acid side chains 4. For analytical applications, slightly acidic to neutral pH (5.8-7.5) is preferred to minimize non-enzymatic ATP hydrolysis while maintaining adequate CK activity 25.

The use of catalytic ATP concentrations (1 equivalent per 60-100 equivalents of substrate) represents an economically optimized approach that balances reaction rate with reagent cost 4. Higher ATP concentrations accelerate the reaction but offer diminishing returns, while lower concentrations extend reaction time without proportional cost savings 4. This catalytic strategy is feasible because ATP is regenerated in situ by the coupled enzyme system, maintaining sufficient ATP levels throughout the reaction 4.

Applications Of Creatine Phosphate In Bioenergetics Research And Clinical Diagnostics

Creatine phosphate serves dual roles as a high-energy phosphate reservoir in cellular metabolism and as a critical reagent in clinical enzyme assays. Understanding reaction yields in both contexts is essential for optimizing production and application protocols.

Bioenergetics And Cellular Energy Metabolism

In muscle cells and neurons, creatine phosphate functions as a temporal and spatial energy buffer, rapidly regenerating ATP during periods of high energy demand 6. The CK-catalyzed reaction maintains ATP homeostasis by:

  • Buffering ATP levels: Creatine phosphate donates its phosphate group to ADP, regenerating ATP within milliseconds 6
  • Facilitating energy transport: The creatine/creatine phosphate shuttle transports high-energy phosphate from mitochondria to sites of ATP utilization 6
  • Delaying fatigue: Sustained ATP availability during intense exercise delays the onset of muscular fatigue 6

Creatinol O-phosphate, a synthetic analog, exhibits similar bioenergetic properties and has been investigated for therapeutic applications in ischemia and oxygen deficiency conditions 6. The synthesis of this compound via protected intermediate routes achieves high yields and purity, enabling pharmaceutical development 6.

Clinical Diagnostics And Myocardial Infarction Detection

Creatine kinase activity measurement is a cornerstone of clinical diagnostics, particularly for detecting myocardial infarction and assessing cardiac damage severity 357810. Elevated serum CK levels indicate tissue damage and enzyme release into circulation, with the magnitude of elevation correlating with infarct size 3.

The bioluminescence-based CK assay offers several advantages for clinical applications:

  • High sensitivity: Detection limits in the picomolar range enable early diagnosis 25
  • Rapid results: Light emission is instantaneous, providing real-time measurements 25
  • Small sample volumes: Suitable for point-of-care testing with fingerstick blood samples 810
  • Dried blood compatibility: Samples can be collected on filter paper and analyzed after storage 810

The correlation between bioluminescence and spectrophotometric methods validates the accuracy of both approaches, with correlation coefficients typically exceeding 0.95 across the clinical range 810. This concordance ensures that yield optimization strategies developed using one method are applicable to the other.

Pharmaceutical Production And Quality Control

Industrial production of creatine phosphate for pharmaceutical applications requires stringent quality control to ensure product purity and potency. The enzymatic synthesis route offers advantages in this context due to:

  • High specificity: Enzymatic catalysis minimizes side product formation 4
  • Mild conditions: Low temperatures and neutral pH preserve product integrity 4
  • Scalability: Reaction volumes can be increased without loss of efficiency 4
  • Environmental compatibility: Non-toxic reagents and minimal waste generation 14

The synthesis method employing urea and sodium sarcosinate for creatine production exemplifies environmentally friendly manufacturing, achieving 73.66% yield with simple operations and low environmental impact 1. This creatine can then be converted to creatine phosphate via the enzymatic route, providing a complete production pathway from inexpensive starting materials 14.

Process Optimization Strategies For Maximizing Creatine Phosphate Reaction Yield

Achieving maximal reaction yield in creatine phosphate synthesis requires systematic optimization of multiple interdependent parameters. Based on the retrieved patent literature, the following strategies have proven effective:

Substrate Ratio Optimization

Using an excess of creatine relative to phosphate donor (3-phosphoglyceric acid or ATP) drives the equilibrium toward product formation 4. A molar ratio of 1.5:1 to 2:1 (creatine:phosphate donor) is recommended, balancing yield enhancement with reagent economy 4. For ATP, catalytic quantities (1:60 to 1:100 relative to substrate) are sufficient due to in situ regeneration 4.

pH Control And Buffer Selection

Maintaining pH at 8.0-9.0 throughout the reaction maximizes CK activity and product stability 4. Suitable buffers include:

  • Tris(hydroxymethyl)aminomethane: Effective pH range 7.0-9.0, minimal enzyme inhibition 7
  • Imidazole: Good buffering capacity at pH 6.5-7.5, compatible with most enzymes 7
  • Triethanolamine: Broad pH range, suitable for alkaline conditions 7

Buffer concentration should be 50-200 mM to maintain

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
BOEHRINGER MANNHEIM GMBHClinical diagnostics for myocardial infarction detection, point-of-care testing with dried blood samples, and pharmaceutical quality control for creatine phosphate production monitoring.CK Bioluminescence Assay KitAchieves 80-90% creatine phosphate yield in 1 hour at 32-40°C using firefly luciferase-luciferin system with diadenosine pentaphosphate inhibition of adenylate kinase, enabling high-sensitivity ATP detection for CK activity measurement.
JIANGSU YUANYANG PHARMACEUTICAL CO. LTD.Large-scale pharmaceutical manufacturing of creatine as precursor for creatine phosphate production, dietary supplement production, and sports nutrition applications.Creatine Synthesis ProcessAchieves 73.66% yield (222.5 kg product) through environmentally friendly synthesis from urea and sodium sarcosinate under vacuum conditions with simple operations and low-cost raw materials.
MITSUBISHI PETROCHEMICAL CO. LTD.Clinical laboratories for cardiac enzyme testing, research applications in bioenergetics studies, and quality control in enzymatic creatine phosphate synthesis processes.CK Activity Measurement SystemUtilizes phosphoglycerate kinase and glyceraldehyde-3-phosphate dehydrogenase coupled enzyme system to quantify creatine phosphate formation through NADH oxidation monitoring at 340 nm with excellent storage stability.
LKB-PRODUKTER ABDried blood specimen analysis, emergency cardiac diagnostics, field testing environments, and epidemiological screening programs requiring sample stability.CK Determination Method for ATP-Containing SamplesEmploys 125 mM AMP pretreatment to decompose endogenous ATP followed by bioluminescence detection with 0.2 μM diadenosine pentaphosphate, achieving correlation >0.95 with spectrophotometric methods.
TIANJIN TIANCHENG PHARMACEUTICAL CO. LTD.Pharmaceutical production for ischemia treatment, oxygen deficiency therapy, sports medicine applications, and bioenergetic research requiring high-purity creatine phosphate analogs.Creatinol O-Phosphate SynthesisUtilizes sulfuric acid protection strategy to form creatinol sulfate transition state before phosphorylation with POCl₃, significantly reducing N-substituted impurities and enhancing reaction selectivity and yield.
Reference
  • Synthesis method for creatine
    PatentWO2014121648A1
    View detail
  • Method and reagent for the determination of creatine kinase
    PatentInactiveUS4286057A
    View detail
  • Creatine kinase determination - using N-acetyl cystein as activator in reaction of creatine phosphate and ADP to form creatine and ATP
    PatentInactiveFR2214887A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png